Addressing Cardiotoxicity Risks in Long-term Use of Human Epidermal Growth Factor Receptor 2 Inhibitors

Intern Med. 2024 Oct 18. doi: 10.2169/internalmedicine.4660-24. Online ahead of print.

Author

Kazuko Tajiri^{1

2}

Affiliations

¹ Department of Cardiology, National Cancer Center Hospital East, Japan.
² Tsukuba Life Science Innovation Program (T-LSI), School of Integrative and Global Majors (SIGMA), University of Tsukuba, Japan.

PMID: 39428519
DOI: 10.2169/internalmedicine.4660-24

No abstract available

Keywords: CTRCD; Onco-cardiology; breast cancer; cancer therapy-related cardiac dysfunction; cardio-oncology; heart failure.